PRODUCT DESCRIPTION
CelProtect by Panaxea is an anti-tumoural combination of Isolates effecting induction of apoptosis, promoting anti-angiogenisis, and inhibition of several pro-inflammatory cytokines. CelProtect can be used for breast, prostate and colorectal cancers.
Indications:
Primary:
- Oncology (Breast, Prostate, Colon, Lymphoma)
- Triple Negative breast Ca
Secondary:
- Diabetic retinopathy
- Low immunity
- Systemic Inflammation
RECOMMENDED USAGE
Take two to five capsules, one to two times daily
COMPOSITION
Serving size: 2 capsule | Amount per serving |
Radix Peuraria lobata (Ge Gen) contains: standardized Daidzein) |
55 mg |
Semen Sojae Praeparatum (Dan Dou Chi) contains: standardized Glycitein) |
32 mg |
Sojae Praeparatum (Dan Dou Chi) contains: standardized Genistein |
16 mg |
Radix Scutellariae Baicalensis (Huang Qin) contains: standardized Baicalein |
400mg |
Radix Scutellariae Baicalensis (Huang Qin) contains: standardized Baicalein |
296 mg |
Fructus Gardeniae Jasminoidis (Zhi Zi) contains: standardized Jasminoidin |
200 mg |
OTHER INGREDIENTS
Vegetable cellulose (hypromellose), vegetable stearic acid, microcrystalline cellulose and vegetable magnesium stearate
Contains: Soy
DOES NOT CONTAIN
Wheat, gluten, soy, milk, eggs, fish, crustacean shellfish, tree nuts and peanuts
STORAGE
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
PRODUCT FORM
Capsule
WARNINGS/CONTRAINDICATIONS
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
Caution: If the Gleason grade is above 2 and the total score is greater than 6, Genistein (CelProtect) is only to be used with radio and/or chemotherapy.
CelProtect may enhance these treatments. Below these levels CelProtect is the recommended protocol and hormone therapy is NOT recommended.
Warning: Contraindicated in pregnancy and breast-feeding.
May be contraindicated with estrogen dependant breast cancer depending on dosage.
Contraindicated in cases of diabetes.
Please review package insert (if available) for further information.